TWEAK R/TNFRSF12 Antibody (enavatuzumab) [Janelia Fluor™ 635], Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB527150-Each-of-1 | In Stock | ₹ 33,747.02 |
NB527150 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 33,747.02
GST (18%): ₹ 6,074.464
Total Price: ₹ 39,821.484
Antigen
TWEAK R/TNFRSF12
Classification
Monoclonal
Conjugate
Janelia Fluor 635
Gene Alias
CD266, CD266 antigen, FGF-inducible 14, Fibroblast growth factor-inducible immediate-early response protein 14, FN14tumor necrosis factor receptor superfamily member 12A, tumor necrosis factor receptor superfamily, member 12A, TweakR, Tweak-receptor, type I transmembrane protein Fn14
Immunogen
TNFRSF12A/ TWEAKR/ CD266
Quantity
0.1 mL
Research Discipline
Angiogenesis, Apoptosis, Biologically Active Proteins, Cancer, Tumor Suppressors
Gene ID (Entrez)
51330
Content And Storage
Store at 4°C in the dark.
Isotype
IgG1
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
enavatuzumab
Formulation
50mM Sodium Borate
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Related Products
Description
- TWEAK R/TNFRSF12 Monoclonal antibody specifically detects TWEAK R/TNFRSF12 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay